Literature DB >> 6338896

The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.

J A Habeshaw, D Bailey, A G Stansfeld, M F Greaves.   

Abstract

Five samples of tonsil, 10 reactive lymph nodes and 65 consecutive cases of non-Hodgkin lymphoma (NHL) were evaluated in suspension phenotyping with the monoclonal antibodies alpha Leu-I, alpha Leu-2a, alpha Leu-3a, OKT1, OKT3, OKT4, OKT6, OKT8, W6/32, 26/114, DA-2, 2DI, J5, AN51 and OKT9 together with conventional surface marking by rosetting (E, Fc gamma, Fc mu, C3b, C3d) and staining for surface and cytoplasmic immunoglobulin (SIg, CyIg) heavy and light chain classes. The results confirm the reproductability and specificity of staining with monoclonal antibodies against T cells and T cells subsets. Evidence is presented for reactivity of alpha Leu-I antibody with SIg positive and Ia positive cells in some lymphomas (centroblastic centrocytic, lymphocytic and immunoblastic), and 2 cases showed evidence of marking with OKT3 on SIg positive cells in T cell predominant immunoblastic lymphoma. Lymphoblastic lymphomas of T cell type expressed the marker OKT6. On the basis of these results criteria for the diagnosis of T cell lymphoma are suggested. The monoclonal antibody J5, reactive with C-ALL antigen, showed variable positivity, occasionally strong in B cells in cases of centroblastic and centrocytic follicular lymphoma. Proportions of cells staining with the monoclonal antibody OKT9 showed a correlation between levels of cellular expression of transferrin (trf) receptor and the histological grade of malignancy, OKT9+ cells being elevated in high grade lymphomas, and in some cases of transforming lymphoma of low grade histological class. These results are discussed and indicate the advantage of employing a wide range of defined monoclonal reagents in the phenotypic evaluation of NHL.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338896      PMCID: PMC2011301          DOI: 10.1038/bjc.1983.52

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  50 in total

1.  [Immunochemical and immunocytological findings in non-Hodgkin's-lymphomas].

Authors:  H Stein
Journal:  Hamatol Bluttransfus       Date:  1976

2.  Functional markers: a new perspective on malignant lymphomas.

Authors:  E S Jaffe; R C Braylan; K Nanba; M M Frank; C W Berard
Journal:  Cancer Treat Rep       Date:  1977-09

3.  Description of the cells from the lymph nodes of patients with non-Hodgkin's lymphoma according to some B- and T-cell characteristics.

Authors:  G Stathopoulos; M Papamichail; E J Holborow; A J Davies
Journal:  Br J Exp Pathol       Date:  1977-02

4.  B and T cell lymphomas. Analysis of blood and lymph nodes in 87 patients.

Authors:  K J Gajl-Peczalska; C D Bloomfield; P F Coccia; H Sosin; R D Brunning; J H Kersey
Journal:  Am J Med       Date:  1975-11       Impact factor: 4.965

5.  Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.

Authors:  R A Miller; D G Maloney; R Warnke; R Levy
Journal:  N Engl J Med       Date:  1982-03-04       Impact factor: 91.245

6.  Monoclonal antibodies OKT 11 and OKT 11A have pan-T reactivity and block sheep erythrocyte "receptors".

Authors:  W Verbi; M F Greaves; C Schneider; K Koubek; G Janossy; H Stein; P Kung; G Goldstein
Journal:  Eur J Immunol       Date:  1982-01       Impact factor: 5.532

7.  Monoclonal antibody to human platelet glycoprotein I. I. Immunological studies.

Authors:  A J McMichael; N A Rust; J R Pilch; R Sochynsky; J Morton; D Y Mason; C Ruan; G Tobelem; J Caen
Journal:  Br J Haematol       Date:  1981-12       Impact factor: 6.998

8.  Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia.

Authors:  F Caligaris-Cappio; M Gobbi; M Bofill; G Janossy
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

9.  Distribution of T-lymphocyte subsets in Hodgkin's disease characterized by monoclonal antibodies.

Authors:  M S Dorreen; J A Habeshaw; P F Wrigley; T A Lister
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

10.  Correlation of surface receptors with histological appearance in 29 cases of non-Hodgkin lymphoma.

Authors:  J A Habeshaw; R A Macaulay; A E Stuart
Journal:  Br J Cancer       Date:  1977-06       Impact factor: 7.640

View more
  14 in total

1.  Flow cytometric analysis of immunoglobulin heavy chain expression in B-cell lymphoma and reactive lymphoid hyperplasia.

Authors:  David D Grier; Samer Z Al-Quran; Diana M Cardona; Ying Li; Raul C Braylan
Journal:  Int J Clin Exp Pathol       Date:  2012-02-12

2.  Isolation and characterization of Leu 7+ germinal-center cells with the T helper-cell phenotype and granular lymphocyte morphology.

Authors:  A Velardi; A B Tilden; R Millo; C E Grossi
Journal:  J Clin Immunol       Date:  1986-05       Impact factor: 8.317

3.  Normal values for the different classes of venous blood mononuclear cells defined by monoclonal antibodies.

Authors:  L K Goff; J A Habeshaw; M L Rose; J A Gracie; W Gregory
Journal:  J Clin Pathol       Date:  1985-01       Impact factor: 3.411

4.  Two monoclonal antibodies raised against a Burkitt lymphoma cell line recognise different cell types within lymphoid follicles.

Authors:  L J Murray; S Dhut; L C Walker; M Rainey; J A Habeshaw
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

5.  Lymphoproliferations in the bone marrow: identification and evolution, classification and staging.

Authors:  R Bartl; B Frisch; R Burkhardt; K Jäger; R Pappenberger; G Hoffmann-Fezer
Journal:  J Clin Pathol       Date:  1984-03       Impact factor: 3.411

6.  Soluble transferrin receptor and iron status in elderly patients.

Authors:  Franz Böhmer; Thomas Frühwald; Alexander Lapin
Journal:  Wien Med Wochenschr       Date:  2003

7.  Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).

Authors:  T Al Saati; G Laurent; P Caveriviere; F Rigal; G Delsol
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

8.  Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse.

Authors:  S H Swerdlow; J A Habeshaw; L J Murray; H S Dhaliwal; T A Lister; A G Stansfeld
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

9.  Analysis of a murine B cell lymphoma, CH44, with an associated non-neoplastic T cell population. I. Proliferation of normal T lymphocytes is induced by a secreted product of the malignant B cells.

Authors:  P B Willoughby; J C Jennette; G Haughton
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

10.  Characteristics of Sternberg-Reed, and related cells in Hodgkin's disease: an immunohistological study.

Authors:  M S Dorreen; J A Habeshaw; A G Stansfeld; P F Wrigley; T A Lister
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.